Phase I study of 21 days continuous infusion with vindesine
Br J Cancer
.
1989 Mar;59(3):471-2.
doi: 10.1038/bjc.1989.97.
Authors
E G de Vries
1
,
E F Smit
,
D E Vendrig
,
J J Holthuis
,
N H Mulder
Affiliation
1
Department of Internal Medicine, University Hospital Groningen, The Netherlands.
PMID:
2930717
PMCID:
PMC2247064
DOI:
10.1038/bjc.1989.97
No abstract available
MeSH terms
Adult
Aged
Drug Administration Schedule
Drug Evaluation
Female
Humans
Infusion Pumps*
Male
Middle Aged
Nervous System Diseases / chemically induced
Vindesine / administration & dosage*
Vindesine / adverse effects
Substances
Vindesine